Techmediabreaks Nightfood Holdings Inc. (OTCQB: NGTF) Subsidiary Techforce Deploys Autonomous Lab Robot In Pharmaceutical Automation Milestone
TechForce said the deployment completed the initial operational goals established under the companies' April 2026 collaboration agreement and will provide operational data and workflow insights to support future automation initiatives. The companies plan to continue evaluating opportunities in laboratory logistics, manufacturing support, AI-enhanced workflows and other automation applications, while Nightfood views healthcare, life sciences and pharmaceutical manufacturing as significant long-term growth markets for its Robotics-as-a-Service platform.
To view the full press release, visit
About Oncotelic Therapeutics, Inc. (OTCQB: OTLC)
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products. The Company's mission is to address high-unmet-need cancers and rare pediatric indications with innovative, late-stage therapeutic candidates.
For more information about Oncotelic Therapeutics, visit .
About Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood Holdings, Inc. (dba TechForce Robotics) is focused on the development, integration, and deployment of AI-enhanced automation solutions across multiple commercial industries. Through its TechForce Robotics platform, the Company develops and deploys autonomous robotic systems designed to improve operational efficiency, workflow consistency, and scalability across hospitality, foodservice, commercial, laboratory, and emerging enterprise automation environments. The Company combines advanced hardware, intelligent AI-enhanced software, and scalable operational infrastructure to support long-term growth through its Robotics-as-a-Service (RaaS) model. For more information, visit .
About TechForce Robotics, Inc.
TechForce Robotics, Inc., a subsidiary of Nightfood Holdings, Inc., is an emerging robotics company focused on deploying AI-enhanced automation across multiple industries. The Company develops, deploys, and scales autonomous robotic solutions for hospitality, foodservice, commercial, and now laboratory and pharmaceutical applications. TechForce operates through a vertically integrated platform combining proprietary robotics technology, real-world operating environments, and scalable manufacturing, and delivers its solutions through a Robotics-as-a-Service (RaaS) model. For more information, visit .
NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company's newsroom at
About TechMediaWire
TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 75+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today's market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment